We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.79B
AUM Growth
+$164M
Cap. Flow
-$30.9M
Cap. Flow %
-1.11%
Top 10 Hldgs %
20.45%
Holding
3,380
New
284
Increased
506
Reduced
861
Closed
334

Top Buys

Rank Stock Value
1
AFL icon
Aflac
AFL
+$2.88M
2
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$2.53M
3
TRGP icon
Targa Resources
TRGP
+$2.39M
4
UNP icon
Union Pacific
UNP
+$2.39M
5
G icon
Genpact
G
+$2.13M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$5.13M
2
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$3.96M
3
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$3.79M
4
PTC icon
PTC
PTC
+$3.74M
5
KSU
Kansas City Southern
KSU
+$3.63M

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Financials 10.71%
3 Consumer Discretionary 10.62%
4 Healthcare 9.54%
5 Industrials 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCOR icon
2676
Comscore
SCOR
$91.6M
$22K ﹤0.01%
216
– –
SGC icon
2677
Superior Group of Companies
SGC
$210M
$22K ﹤0.01%
933
– –
USLM icon
2678
United States Lime & Minerals
USLM
$3.37B
$22K ﹤0.01%
780
– –
VHC icon
2679
VirnetX Holding Corp
VHC
$64.8M
$22K ﹤0.01%
254
– –
VMD icon
2680
Viemed Healthcare
VMD
$349M
$22K ﹤0.01%
3,037
– –
VRA icon
2681
Vera Bradley
VRA
$94.7M
$22K ﹤0.01%
1,814
– –
QTTB icon
2682
Q32 Bio
QTTB
$458M
$22K ﹤0.01%
167
– –
TRVN
2683
DELISTED
Trevena, Inc.
TRVN
$22K ﹤0.01%
+21
New +$23.5K
ONCR
2684
DELISTED
Oncorus, Inc.
ONCR
$22K ﹤0.01%
1,601
+1,046
+188% +$16.2K
RXDX
2685
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$22K ﹤0.01%
+886
New +$19.8K
ATHX
2686
DELISTED
Athersys, Inc. Common Stock
ATHX
$22K ﹤0.01%
613
– –
AEVA
2687
Aeva Technologies
AEVA
$1.56B
$21K ﹤0.01%
+389
New +$19.6K
DSGN icon
2688
Design Therapeutics
DSGN
$901M
$21K ﹤0.01%
+1,057
New +$26.7K
EWTX icon
2689
Edgewise Therapeutics
EWTX
$4.69B
$21K ﹤0.01%
+967
New +$26.4K
FBT icon
2690
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
$21K ﹤0.01%
125
– –
FLXS icon
2691
Flexsteel Industries
FLXS
$303M
$21K ﹤0.01%
+521
New +$22.7K
IMCV icon
2692
iShares Morningstar Mid-Cap Value ETF
IMCV
$1.17B
$21K ﹤0.01%
+330
New +$21.3K
INBK icon
2693
First Internet Bancorp
INBK
$256M
$21K ﹤0.01%
680
– –
KRRO icon
2694
Korro Bio
KRRO
$196M
$21K ﹤0.01%
43
– –
MLPX icon
2695
Global X MLP & Energy Infrastructure ETF
MLPX
$3.56B
$21K ﹤0.01%
596
– –
MPB icon
2696
Mid Penn Bancorp
MPB
$971M
$21K ﹤0.01%
771
+372
+93% +$10.1K
ORRF icon
2697
Orrstown Financial Services
ORRF
$855M
$21K ﹤0.01%
900
– –
PCYO icon
2698
Pure Cycle
PCYO
$273M
$21K ﹤0.01%
1,502
– –
RMNI icon
2699
Rimini Street
RMNI
$470M
$21K ﹤0.01%
3,438
+1,568
+84% +$11.5K
RRBI icon
2700
Red River Bancshares
RRBI
$681M
$21K ﹤0.01%
422
– –
106 107
108
109 110

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return

Ameritas Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Ameritas Investment Partners held 3,380 positions worth $2.79B, up 6.2% from $2.62B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Ameritas Investment Partners's Q2 2021 filing shows 284 new, 506 increased, 861 reduced and 334 closed positions. Its largest new stake was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M. The largest sale was Charles River Laboratories, an estimated $5.13M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2021 buy was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M.
  • Ameritas Investment Partners added most to Aflac in Q2 2021, an estimated $2.88M increase.
  • Ameritas Investment Partners's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $5.13M.
  • Ameritas Investment Partners fully exited TCF Financial Corporation Common Stock in Q2 2021, selling an estimated $1.96M.
  • Ameritas Investment Partners's ten largest holdings make up 20% of its $2.79B portfolio in Q2 2021.
  • Ameritas Investment Partners opened 284 new positions and closed 334 in Q2 2021.
  • Ameritas Investment Partners's portfolio value rose 6.2% quarter-over-quarter to $2.79B.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.